ViroGates Net Income vs. Price To Sales

VIRO Stock   13.40  0.90  7.20%   
Based on ViroGates' profitability indicators, ViroGates AS may not be well positioned to generate adequate gross income at the moment. It has a very high risk of underperforming in January. Profitability indicators assess ViroGates' ability to earn profits and add value for shareholders.
For ViroGates profitability analysis, we use financial ratios and fundamental drivers that measure the ability of ViroGates to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well ViroGates AS utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between ViroGates's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of ViroGates AS over time as well as its relative position and ranking within its peers.
  
Check out World Market Map.
Please note, there is a significant difference between ViroGates' value and its price as these two are different measures arrived at by different means. Investors typically determine if ViroGates is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, ViroGates' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

ViroGates AS Price To Sales vs. Net Income Fundamental Analysis

Comparative valuation techniques use various fundamental indicators to help in determining ViroGates's current stock value. Our valuation model uses many indicators to compare ViroGates value to that of its competitors to determine the firm's financial worth.
ViroGates AS is rated first in net income category among its peers. It is rated first in price to sales category among its peers . Comparative valuation analysis is a catch-all model that can be used if you cannot value ViroGates by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for ViroGates' Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.

ViroGates Price To Sales vs. Net Income

Net income is the profit of a company for the reporting period, which is derived after taking revenues and gains and subtracting all expenses and losses. Net income is one of the most-watched numbers by money managers as well as individual investors.

ViroGates

Net Income

 = 

(Rev + Gain)

-

(Exp + Loss)

 = 
(17.66 M)
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
Price to Sales ratio is typically used for valuing equity relative to its own past performance as well as to performance of other companies or market indexes. In most cases, the lower the ratio, the better it is for investors. However, it is advisable for investors to exercise caution when looking at price-to-sales ratios across different industries.

ViroGates

P/S

 = 

MV Per Share

Revenue Per Share

 = 
16.38 X
The most critical factor to remember is that the price of equity takes a firm's debt into account, whereas the sales indicators do not consider financial leverage. Generally speaking, Price to Sales ratio shows how much market values every dollar of the company's sales.

ViroGates Price To Sales Comparison

ViroGates is currently under evaluation in price to sales category among its peers.

ViroGates Profitability Driver Comparison

Profitability drivers are factors that can directly affect your investment outlook on ViroGates. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of ViroGates position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the ViroGates' important profitability drivers and their relationship over time.

Use ViroGates in pair-trading

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if ViroGates position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in ViroGates will appreciate offsetting losses from the drop in the long position's value.

ViroGates Pair Trading

ViroGates AS Pair Trading Analysis

The ability to find closely correlated positions to ViroGates could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace ViroGates when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back ViroGates - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling ViroGates AS to buy it.
The correlation of ViroGates is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as ViroGates moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if ViroGates AS moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for ViroGates can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Use Investing Themes to Complement your ViroGates position

In addition to having ViroGates in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Candy and Soda Thematic Idea Now

Candy and Soda
Candy and Soda Theme
Fama and French investing themes focus on testing asset pricing under different economic assumptions. The Candy and Soda theme has 13 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Candy and Soda Theme or any other thematic opportunities.
View All  Next Launch

Other Information on Investing in ViroGates Stock

To fully project ViroGates' future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of ViroGates AS at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include ViroGates' income statement, its balance sheet, and the statement of cash flows.
Potential ViroGates investors and stakeholders can use historical trends found within financial statements to determine how well the company is positioned for the future. Although ViroGates investors may work on each financial statement separately, they are all related. The changes in ViroGates's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on ViroGates's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet but not equivalent to net income shown on the income statement. Please read more on our technical analysis and fundamental analysis pages.